IMPORTANCE An estimated 4 to 5 million Americans have Alzheimer disease or another dementia.
I n the United States, Alzheimer disease and related dementias affect an estimated 4 to 5 million persons. 1 Dementia is a chronic disease that requires comprehensive medical and social services to provide high-quality care and prevent complications and hospitalizations. 2 This care is expensive, with annual estimated costs of $157 billion to $215 billion in 2010. The total societal costs of dementia are expected to increase nearly 80% by 2040.
3
Treating patients with dementia requires coordinating social services and medical care, instructing caregivers, and counseling families. The quality of care for dementia is poor compared with that for other diseases that affect older persons. [4] [5] [6] Community resources (eg, the Alzheimer Association) can help improve the quality of care, especially by providing patient education and support for caregivers. 7 However, communitybased resources are underutilized 7 and are poorly integrated within the health care system. Several dementia care programs have been developed to more comprehensively meet the needs of patients and their families. These programs have relied on care coordinators and software to increase the quality of dementia care, improve patient health-related quality of life, and reduce caregiver stress. [8] [9] [10] [11] Most of these programs have not evaluated effects on health care utilization; however, the program at Indiana University's Healthy Aging Brain Center reports potential cost savings owing to the lower numbers of emergency department visits, inpatient hospitalizations, and 30-day readmissions in the program participation group than in the standard care group.
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The Alzheimer and Dementia Care program at the University of California, Los Angeles (UCLA), 13 a comprehensive dementia care program with comanagement by nurse practitioners, was launched in November 2011. In July 2012, the program received additional support from the Centers for Medicare & Medicaid Services (CMS). The program provides high-quality dementia care, with pass rates exceeding 90% on widely accepted dementia quality indicators. 14 To determine the health care utilization and cost outcomes of the program, CMS contracted with NORC at the University of Chicago to conduct an independent external evaluation.
Methods
The UCLA institutional review board did not consider this study to be human subject research, and patient written informed consent was not required. The UCLA and NORC institutional review boards approved secondary analyses of health care utilization data.
Description of the Clinical Program
The program is based at an academic health care system and partners with community-based organizations to provide comprehensive, coordinated, patient-centered dementia care. Program goals are to maximize patient function, independence, and dignity; minimize caregiver strain; and reduce unnecessary costs through improved care. The program uses a comanagement model between nurse practitioners, who are dementia care managers, and physicians. 13 The Box lists the 5 key program components. Each dementia care manager is responsible for up to 250 patients, with 2 assistants supporting 5 dementia care managers. 15 We selected 2 patients from the comparison group for each program participant using propensity scores with nearestneighbor matching without replacement. The propensity score
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Key Points
Question What are the health care utilization and cost outcomes of a comprehensive dementia care program for Medicare beneficiaries?
Findings In a case control study that used a quasiexperimental design to assess the health care utilization of 3249 patients with dementia, those patients in a dementia care program were less likely to be admitted to a long-term care facility than patients in a propensity score-matched control group. After accounting for implementation costs, the program was cost neutral.
Meaning Comprehensive dementia care programs may help more patients stay in community-based settings and was cost neutral.
used logistic regression to model the odds of program enrollment, based on the patient's covariates. The propensity score model included Alzheimer-type dementia, age, sex, race/ ethnicity, prior cancer diagnosis, chronic obstructive pulmonary disease, heart disease, arthritis, hyperlipidemia, chronic kidney disease, hip fracture, depression, prior-year health care utilization (emergency department visits, hospitalizations), dual Medicare and Medicaid eligibility, prior-year Hierarchical Condition Category (HCC) score, 16 prior costs (costs during the prior quarter, costs for the prior year, and a ratio of costs in the prior quarter compared with total costs over the last year), and duration of dementia (years since the first claim with a dementia ICD-9 diagnosis code looking back to 1999). Overlap in distribution of estimated propensity scores across intervention and comparison groups and covariate balance were assessed before and after applying the scores. 17 
Outcome Measures
Entry to a long-term care facility was defined at the patient level as at least 3 consecutive months of Medicare Part B claims, with a skilled-nursing facility listed as the place of service. 
Time Periods
Preintervention and postintervention time periods were defined based on the enrollment or pseudoenrollment date for each patient. Preintervention time included the 8 quarters (2 years) prior to the enrollment or pseudoenrollment date. The postintervention period was limited to 12 quarters (3 years); the sample size became too small to conduct analyses beyond 12 quarters.
Analysis
For analysis of long-term care placement, we used the stratified extension to the Fine-Gray proportional hazard models adjusted for age, sex, race (black), ethnicity (Hispanic), HCC score, and Alzheimer-type dementia to estimate the relative subhazard of long-term care placement for patients in the intervention and comparison groups. [21] [22] [23] This competing risk regression model accounted for 198 patients in the intervention group (18.2%) and 614 patients in the comparison group (28.3%) who died without entering a long-term care facility. For the other utilization measures and cost of care, we used difference-in-difference analyses to estimate the average treatment effect by comparing the average outcomes of patients in the program and comparison groups across preintervention and postintervention periods. 24 We used multilevel mixed-effects generalized linear models with the appropriate functional form (ie, binomial for utilization outcomes and linear for costs) to estimate the program's influence. Random intercepts were allowed for matched sets of program and comparison patients. Fixed effects in the model included a treatment group indicator; a vector of dummy variables for time, including up to 8 quarters before and 12 quarters after enrollment; difference-in-difference estimator in each quarter after implementation (ie, treatment and time vector interaction term); and a vector of participant characteristics including age, sex, race (black), ethnicity (Hispanic), HCC score, Alzheimer-type dementia, and days of fee-for-service coverage in a quarter. Similar to the total estimates obtained in survey sampling, we obtained overall estimates for the entire implementation period by weighting each quarterly estimate by the number of participants enrolled in that quarter. We then estimated the program's average quarterly influence using weighted quarter-specific estimates. All analyses were performed using Stata software, version 14 (StataCorp). 25 
Results
Of the 1426 program participants who were enrolled in the program on or before December 31, 2015, 1083 were enrolled in fee-for-service Medicare. Table 1 summarizes demographic and other baseline information for patients in the intervention and comparison groups. About two-thirds of patients in the intervention group were women (n = 701), 28.3% were non-white (n = 308), and 15.3% were dual enrolled in Medicare and Medicaid (n = 166). Additional demographic and clinical characteristics of the program cohort and their caregivers are provided in eAppendix 2 in the Supplement.
The Figure shows the cumulative incidence of admission to a long-term care nursing home for patients in the program and comparison group. Time to nursing home admission was delayed for program participants. Program participants were less likely than patients in the comparison group to be admitted to a long-term care facility (hazard ratio, 0.60; 95% CI, 0.59-0.61).
In regression models, hospital and emergency department utilization did not differ between intervention and comparison groups ( Table 2) . Total costs of care for Medicare were lower for program participants than for patients in the comparison group ($601 less per patient per quarter, 95% CI, −$1198 to −$5; P < .048). Total program costs per patient per quarter were estimated to be $317. After accounting for program costs, the program was cost neutral for Medicare, with an estimated net cost of −$284 (95% CI, −$881 to $312) per program participant per quarter.
Discussion
In this study of a comprehensive dementia care comanagement program, the number of long-term care nursing home placements was reduced for Medicare fee-for-service beneficiaries, and the total costs of care for Medicare were lower for program participants than for patients in the comparison group. However, after accounting for program costs, the program was cost neutral.
Comanagement of dementia care allows nurse practitioners to focus on comprehensive care of dementia while allowing the primary care physician to retain responsibility for the clinical treatment of dementia and other conditions. Similar collaborative models of care have been valuable in improving the quality of care, outcomes, and sometimes the cost of care for conditions such as depression 26 and heart failure. 27, 28 This study built on the earlier findings from the Indiana University Healthy Aging Brain Center, which initially relied on nurse practitioners to comanage treatment of patients with dementia and was conducted in a safety-net population. 9, 12 We found that it is feasible to provide collaborative care for dementia that is cost neutral in a predominantly fee-forservice health care environment. If implemented widely, program return on investment would depend on local costs of implementation, particularly local labor costs. 29 At the time of the study, fee-for-service billing, however, did not generate sufficient revenues to fully pay for program costs.
Through new payment mechanisms, the adoption and dissemination of dementia care management services could be facilitated.
Limitations
The limitations of the study should be noted. First, the study was a controlled before-and-after comparison conducted at a single institution and limited to Medicare fee-for-service beneficiaries. Because claims data were lacking, beneficiaries in Medicare Advantage plans were not included in the analysis. The quasiexperimental design is not as strong as a randomized clinical trial from an analytic perspective, but it has pragmatic design features (eg, implementation in real clinical settings, virtually no exclusionary criteria) that are difficult to implement in clinical trials. Although we used a zip code and propensity score-matched comparison group that was similar to the intervention group with regard to sociodemographic and clinical characteristics within claims data, these data do not provide detailed clinical information on disease severity, functional status, or the characteristics of caregivers or referring physicians. All of these factors may affect health care utilization and costs. Although the mean follow-up was about 21 months (7 3-month quarters), only onethird of participants (n = 357) were enrolled in the intervention group for more than 2 years, and analysis was truncated at 3 years of follow-up. Finally, the reduction of long-term nursing home admissions may have been partially or fully offset by increased use of assisted-living facilities; we were unable to assess whether this was the case. For many people, however, the use of assisted living and other community longterm services and support would be preferable to long-term care in a nursing home.
Conclusions
New models of care that are effective without substantial cost increases are needed for patients with Alzheimer disease and other dementias. Comprehensive dementia care addresses several goals of the National Plan to Address Alzheimer Disease, 30 can reduce the number of admissions to long-term care facilities, and depending on program costs, may be cost neutral or cost saving. Wider implementation of such programs may help more people with dementia remain in their communities. 
Non-Personnel Expenses
Community-based organization services $85,000
Care management software maintenance $55,000
Website maintenance $4,125
Travel for dementia care managers $5,000
Telephone, pagers, and computer data plans for dementia care managers $6,540
Program brochures $1,500
Supplies (copying, postage, delivery service, miscellaneous supplies) $9,000 Based on active annual ADC program enrollment of 1250 participants.
